Trulieve Cannabis (TRLV) reported $1.2B in revenue for fiscal 2025, −0.4% year on year. That ranks #1678 by revenue among 2853 SEC filers and #154 in Healthcare. It posted a net loss of −$116M for the same year. Revenue has grown 29.3% a year on average since 2019 ($253M then). The fiscal 2025 balance sheet shows $2.7B in total assets, $256M in cash and $137M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.2B | −0.4% | FY20252025-12-31 |
| Gross profitGrossProfit | $711M | −0.6% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $143M | +46.8% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$116M | +$38.7M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $273M | +0.5% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $44.2M | −64.0% | FY20252025-12-31 |
| Total assetsAssets | $2.7B | −6.1% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | $1.1B | −8.5% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $256M | +7.0% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $137M | −62.5% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $287M | $2.3M | Open → |
| Q2 20262026-06-30 | $271M | −$406M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 142 of 161 companies compared | −9.9% | |
| Operating marginRank 74 of 160 companies compared | 12.1% | |
| Cash as share of revenueRank 46 of 160 companies compared | 21.6% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Trulieve Cannabis Corp.
- Ticker
- TRLV
- Exchange
- NYSE
- SIC classification
- Medicinal Chemicals & Botanical Products (2833)
- Fiscal year end
- 12-31
- CIK
- 0001754195
Filings
- 10-QAug 7, 2026Open filing →
- 10-QMay 7, 2026Open filing →
- 10-KFeb 26, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Indivior PharmaceuticalsINDV | $1.2B | $210M |
| Nasus PharmaNSRX | $1.2B | −$5.9M |
| Bio-TechneTECH | $1.2B | $73.4M |
| Trulieve CannabisTRLV | $1.2B | −$116M |
| Sotera HealthSHC | $1.2B | $77.9M |
| NovavaxNVAX | $1.1B | $440M |
| Prestige Consumer HealthcarePBH | $1.1B | $190M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Trulieve Cannabis — Key figures |url=https://companiesranked.com/en/company/trulieve-cannabis |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Trulieve Cannabis — Key figures. CompaniesRanked. https://companiesranked.com/en/company/trulieve-cannabisBibTeX
@misc{companiesranked-en-company-trulieve-cannabis-2026,
author = {{CompaniesRanked}},
title = {{Trulieve Cannabis — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/trulieve-cannabis}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001754195-26-000019 · February 26, 2026
{{cite web |title=Trulieve Cannabis — Key figures — 10-K (0001754195-26-000019) |url=https://www.sec.gov/Archives/edgar/data/1754195/000175419526000019/tcnnf-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.